Robert G. Perry
Impact in
- Physiology top 10%
- Nutrition and Health in Aging
- Diet and metabolism studies
-
- Diabetes Treatment and Management
- Diet, Metabolism, and Disease
Papers in
-
- Hepatitis C virus research 3
- Hepatocellular Carcinoma Treatment and Prognosis 1
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- Daniel Rooks (2 shared papers)Olivier Pétricoul (2 shared papers)Jens Præstgaard (2 shared papers)Ronenn Roubenoff (2 shared papers)Didier Laurent (2 shared papers)Sam Hariry (1 shared paper)Estelle Lach‐Trifilieff (1 shared paper)Thomas J. Wade (1 shared paper)
- Journals
- Journal of Hepatology (2 papers)Gastroenterology (1 paper)Journal of the American Geriatrics Society (1 paper)JAMA Network Open (1 paper)Clinical Therapeutics (1 paper)
- Partner nations
- United StatesSwitzerlandIndia
In The Last Decade
Robert G. Perry
10 papers receiving 581 citations
Robert G. Perry's Hit Papers
Peers
Comparison fields: 5 of 85
- Physiology 258
- Endocrinology, Diabetes and Metabolism 140
- Cell Biology 101
- Hepatology 49
- Pharmacology 75
Countries citing papers authored by Robert G. Perry
This map shows the geographic impact of Robert G. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert G. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert G. Perry more than expected).
Fields of papers citing papers by Robert G. Perry
This network shows the impact of papers produced by Robert G. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert G. Perry. The network helps show where Robert G. Perry may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert G. Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity Hit paper breakdown → | 2021 | 183 |
| 2 | TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial Hit paper breakdown → | 2021 | 163 |
| 3 | 2017 | 157 | |
| 4 | 2017 | 26 | |
| 5 | 2006 | 19 | |
| 6 | 2015 | 13 | |
| 7 | 2018 | 9 | |
| 8 | 2014 | 9 | |
| 9 | 2015 | 7 | |
| 10 | 2020 | 3 | |
| 11 | Evaluation Of In Situ Chemical Oxidation Of Soils At A Mixed Waste Site And Assessment Of Effects On Ground Water Quality. | 2010 | 1 |
| 12 | 1997 | 0 |
About Robert G. Perry
Robert G. Perry is a scholar working on Hepatology, Infectious Diseases, Molecular Biology, Pharmacology and Epidemiology, having authored 12 papers that have together received 590 indexed citations. Recurring topics across this work include Hepatitis C virus research (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Phytochemistry and Biological Activities (2 papers), HIV/AIDS drug development and treatment (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Body Composition Measurement Techniques (1 paper), Alzheimer's disease research and treatments (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Physiology (258 citations), Endocrinology, Diabetes and Metabolism (140 citations), Cell Biology (101 citations), Hepatology (49 citations) and Pharmacology (75 citations). Robert G. Perry has collaborated with scholars based in United States, Switzerland and India. Frequent co-authors include Daniel Rooks, Olivier Pétricoul, Jens Præstgaard, Ronenn Roubenoff, Didier Laurent, Sam Hariry, Estelle Lach‐Trifilieff, Thomas J. Wade, Ram R. Miller and Steven B. Heymsfield. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Journal of the American Geriatrics Society, JAMA Network Open and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.